TARS
Tarsus Pharmaceuticals, Inc.When TARS passed all Ten ChecksTarsus Pharmaceuticals, Inc.
history · not a forecastOver the past 10 years, TARS has passed all Ten Checks on 2 separate days. Here is how it moved over the 20 trading sessions that followed — how far it rose, and how far it fell.
The strongest of them rose +19.1% in Oct 2025, peaked day 17.
- Oct 2025+19.1% -1.3%
- Nov 2024+14.8% +4.0%
Peak and dip mark the highest and lowest closing prices over those 20 sessions; the intraday swings ran wider still, and neither figure is a return you could have captured by buying and selling at the perfect moment. These are historical readings from the past 10 years, drawn only from the US-listed stocks the site covers today — a record of what happened, not a prediction of what will, and not investment advice.
6-month history — checks vs. price
Price on the left axis; checks passing (0–10) on the right.
Common questions about TARS’s checks
How many technical checks does TARS pass right now?
As of the Aug 13, 2026 close, TARS passes 7 of 10 fixed technical checks — the checks not passing: pulled back to support, not overextended, stop distance within range.
Why does TARS fail the "stop distance within range" check?
A stop at $57.62 is 16.3% below TARS's price — wider than the 8% ceiling, so the risk check fails (too much risk per share). It passes once that distance is back inside 2–8%.
What price would change TARS's check count?
The nearest flip level is "holding above short-term average" fails on a close below $64.44. Each price-anchored check has an exact next-close level, shown in the Flip levels panel above.
Factual measurements from the latest scan — not investment advice.